Mustargen (RECORDATI RARE DISEASES, INC.)


Welcome to the PulseAid listing for the Mustargen drug offered from RECORDATI RARE DISEASES, INC.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: RECORDATI RARE DISEASES, INC.
NON-PROPRIETARY NAME: mechlorethamine hydrochloride
SUBSTANCE NAME: MECHLORETHAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRACAVITARY; INTRAVENOUS
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1949-03-15
END MARKETING DATE: 0000-00-00


Mustargen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMustargen from RECORDATI RARE DISEASES, INC.
LABELER NAME: RECORDATI RARE DISEASES, INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/10mL)
START MARKETING DATE: 1949-03-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55292-911_f403750e-2b49-9dc7-8139-7563864ac611
PRODUCT NDC: 55292-911
APPLICATION NUMBER: NDA006695

Other MECHLORETHAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RECORDATI RARE DISEASES, INC.Mustargen